Grow Everything Biotech Podcast

169. AI, Antivenom, and Antibodies: Previewing SynbioBeta with John Cumbers

Feb 20, 2026
John Cumbers, founder of SynBioBeta and synthetic biology connector, returns to preview big trends. He discusses universal antivenom work, how AI is reshaping organism design, and China’s manufacturing edge. Short takes cover self-driving labs, stem cell tissue banks, longevity research, and why a biology 'ChatGPT moment' may be near.
Ask episode
AI Snips
Chapters
Books
Transcript
Episode notes
ANECDOTE

From Snake Bites To Universal Antivenom

  • Tim Freedy deliberately allowed himself to be bitten by many snakes and built up a broad antibody repertoire.
  • John Cumbers described sequencing Freedy's antibodies to develop universal antivenom for global use.
ANECDOTE

SynBioBeta's Community Origin Story

  • John Cumbers founded SynBioBeta 14 years ago to connect curious people and accelerate biotech progress.
  • He runs it as a single annual hub event to maximize community value and high-impact networking.
INSIGHT

CPGs Signal Real Demand For Biotech

  • Large CPGs like Unilever and P&G are actively partnering with AI enzyme startups to decarbonize supply chains.
  • John Cumbers presented this as strong commercial demand signaling for industrial biotech.
Get the Snipd Podcast app to discover more snips from this episode
Get the app